Management

Per Andersson

Chief Executive Officer

CEO at Xspray Pharma since 2006
Born 1967

Per Andersson has been the CEO of Xspray Pharma AB since 2006. Per Andersson has extensive experience from the medical industry, especially within patent work and strategies. Previous positions include Science Director at Gyros AB and Scientist at GE Healthcare

Education: Ph.D. in Analytical Chemistry, Stockholm university

Other current activities: Other current activities: Chairman of the board of Robotic Lawn Care Sweden AB and Xspray Pharma Futurum AB and deputy board member in Journeyman Stockholm AB

Other board assignments (recent 5 years): Deputy board member in Innovation TBD AB

Holdings: 230,260 shares and 31 267 warrants

Independent in relation to the larger shareholders but not in relation to the company

Andreas Konar

Business Development

Business development at Xspray since 2010
Born 1949

Andreas Konar has 4 decades of experience from the pharmaceutical industry in R&D, clinical research, project management and business development. He has been VP R&D at Dumex and AL Pharma, responsible for the Drug Delivery Business Unit at LifeCycle Pharma, business development at Recordati and section manager at Astra Draco

Education: Associate Professor in Organic Chemistry, University of Lund, Sweden
Ph.D. in Organic Chemistry, University of Lund, Sweden
M.Sc. in Chemical Engineering, Chalmers University of Technology, Gothenburg, Sweden

Other current activities: Member of the Board of Ground Zero Pharmaceuticals, Irvine, CA, USA

Other board assignments (recent 5 years): None

Holdings in the Company: 73,555 shares and 19,091 warrants

Independent in relation to major shareholders but not in relation to the Company

Charlotta Liljebris

VP Research and Development

VP R&D at Xspray Pharma since 2018
Born 1964

Charlotta Liljebris has 30 years of experience from the pharmaceutical industry. She has been responsible for the project portfolio and business development at Orexo, VP R&D at Aprea with focus on oncology and worked in several leading positions within project management at Biovitrum.

Education: Ph.D. in Medicinal Chemistry, Uppsala University, Sweden
M.Sc. in Chemistry, Uppsala University, Sweden

Other current activities: Other current assignments: Deputy board member in Liljebris Consulting AB

Other Board assignments (the rexent 5 years): Member of the Board in Recipharm OT Chemistry, Connect Uppsala and Sprint Bioscience

Holdings in the Company: 2,000 shares and 23,437 warrants

Independent in relation to major shareholders but not in relation to the Company.

Kerstin Hasselgren

Chief Financial Officer

CFO at Xspray Pharma since 2019
Born 1961

Kerstin Hasselgren has broad experience from working in large public international companies as VP Corporate Business Control at SSAB, CFO at Alstom Transport Nordic, VP Finance Global Operations at AstraZeneca and VP Finance Global R&D at AstraZeneca

Education: M.Sc. Business Administration, Stockholm School of Economics

Other current activities: Other current assignments: None

Other Board assignments (the recent 5 years): None

Holdings in the Company: 4,500 shares and 39,538 warrants

Independent in relation to major shareholders but not in relation to the Company